PKU Healthcare

Last updated
PKU Healthcare
FormerlySouthwest Synthetic Pharmaceuticals
Company type public
SZSE: 000788
Industrypharmaceutical
Headquarters
Chongqing
,
China
RevenueDecrease2.svg CN¥2.011 billion (2015)
Decrease2.svg(CN¥45 million) (2015)
Increase2.svg CN¥25 million (2015)
Total assets Decrease2.svg CN¥3.124 billion (2015)
Total equity Increase2.svg CN¥1.133 billion (2015)
Owner
PKU Healthcare Group(40.38%)
China Securities Finance (1.94%)
public shareholders(57.68%)
Parent
SW Pharmaceutical Group(direct)
PKU Healthcare Group(intermediate)
Founder Group (intermediate)
PKU Asset Management(intermediate)
Peking University (intermediate)
Ministry of Education (intermediate)
State Council (ultimate)
Website pku-hc.com
Footnotes /references
in consolidated financial statement
  1. Chongqing Southwest Synthetic Pharmaceutical was later renamed into Southwest Synthetic Pharmaceutical Group (Chinese :西南合成医药集团)

References

  1. "关于变更公司名称的公告" (PDF). Southwest Synthetic Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 25 November 2013. Retrieved 28 February 2017.
  2. "2001 Annual Report" (PDF). Southwest Synthetic Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 19 April 2002. Retrieved 7 March 2017.
  3. "股权托管的公告". Southwest Synthetic Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 12 June 2002. Retrieved 7 March 2017.
  4. "第一大股东签署股权委托管理协议". Southwest Synthetic Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 14 June 2003. Retrieved 7 March 2017.
  5. "控股股东改制". Southwest Synthetic Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 23 September 2003. Retrieved 7 March 2017.
  6. "收购报告书摘要" (PDF). Southwest Synthetic Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 22 October 2003. Retrieved 7 March 2017.
  7. "2015 Annual Report" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 29 April 2016. Retrieved 28 February 2017.
  8. "2012 Annual Report" (PDF). PKU Southwest Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 29 March 2013. Retrieved 28 February 2017.
  9. "简式权益变动报告书(三)" (PDF). Southwest Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 15 June 2013. Archived from the original (PDF) on 1 March 2017. Retrieved 28 February 2017.
  10. "简式权益变动报告书(四)" (PDF). Southwest Pharmaceutical (in Chinese). Shenzhen Stock Exchange. 15 June 2013. Retrieved 28 February 2017.
  11. "2013 Annual Report" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 29 March 2014. Retrieved 28 February 2017.
  12. "北大资源集团控股有限公司的回复" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 21 November 2014. Retrieved 28 February 2017.
  13. "关于收到中国证监会《行政处罚事先告知书》的公告" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 20 December 2016. Retrieved 4 May 2017.[ permanent dead link ]
  14. "简式权益变动报告书" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 12 July 2014. Retrieved 28 February 2017.
  15. "2014 Annual Report" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 28 April 2015. Retrieved 28 February 2017.
  16. "关于股东拟增持公司股份的提示性公告" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 20 November 2014. Retrieved 28 February 2017.
  17. "关于股东增持公司股份的公告" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 27 July 2015. Retrieved 28 February 2017.
  18. "关于股东增持计划实施完成的公告" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 12 October 2015. Retrieved 28 February 2017.
PKU Healthcare Corp., Ltd.
Simplified Chinese 北大医药股份有限公司
Transcriptions